Chronic disease epidemiology, cancer and mobile global approaches to disease prevention

Public Health

Volumn 126, Issue 3, 2012, Pages 206-209

  Linkov, F ^a   Shubnikov, E ^b   Padilla, N ^c   McCallum, A ^d   LaPorte, R ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b NOVOSIBIRSK STATE MEDICAL UNIVERSITY   (Russian Federation)

^c UNIVERSITY OF GUANAJUATO   (Mexico)

^d NHS LOTHIAN   (United Kingdom)

Author keywords

Cancer prevention; Global health; Internet; Supercourse

Indexed keywords

CANCER; DISEASE; DISEASE SPREAD; EPIDEMIOLOGY; INTERNET;

ACCESS TO INFORMATION; ARTICLE; CANCER PREVENTION; CANCER RISK; CHRONIC DISEASE; DISEASE SURVEILLANCE; EPIDEMIOLOGY; HEALTH EDUCATION; INTERNET; LIBRARY; MOBILE PHONE; MORTALITY; PREVALENCE; PUBLIC HEALTH; SPAIN; USSR;

CHRONIC DISEASE; HUMANS; LANGUAGE; NEOPLASMS; PRIMARY PREVENTION; PUBLIC HEALTH; TELEMEDICINE; WORLD HEALTH;

EID: 84858136322     PISSN: 00333506     EISSN: 14765616     Source Type: Journal    
DOI: 10.1016/j.puhe.2011.12.009     Document Type: Article

References (20)

1. LaPorte R.E., Linkov F., Villasenor T., Sauer F., Gamboa C., Lovalekar M., et al. Papyrus to PowerPoint (P 2 P): metamorphosis of scientific communication. BMJ 2002, 325(7378):1478-1481.
2. LaPorte R.E., Marler E., Akazawa S., Sauer F., Gamboa C., Shenton C., et al. The death of biomedical journals. BMJ 1995, 310(6991):1387-1390.
3. Laporte R.E., Sekikawa A., Sa E., Linkov F., Lovalekar M. Whisking research into the classroom. BMJ 2002, 324(7329):99.
4. Linkov F., Shubnikov E., Husseini A.S., Lovalekar M., LaPorte R. Globalisation of prevention education: a golden lecture. Lancet 2003, 362(9395):1586-1587.
5. Linkov F, LaPorte R, Lovalekar M, Dodani S. Web quality control for lectures: Supercourse and Croatian Medical Journal 2005;46(6):875-8. http://Amazon.com.
6. Linkov F., Lovalekar M., LaPorte R. Quality control of epidemiological lectures online: scientific evaluation of peer review. Croat Med J 2007, 48:249-255.
7. Preventing chronic disease: a vital investment. WHO global report 2005, World Health Organization, World Health Organization, Geneva, (last accessed 19.02.12). http://www.who.int/chp/chronic_disease_report/full_report.pdf.
8. Piot P., Ebrahim S. Prevention and control of chronic diseases. BMJ 2010, 341:c4865.
9. Beaglehole R., Bonita R., Magnusson R. Global cancer prevention: an important pathway to global health and development. Public Health 2011, 125(12):821-831.
10. Sullivan R., Purushotham A.D. Avoiding the zero sum game in global cancer policy: beyond 2011 UN high level summit. Eur J Cancer 2011, 47:2375-2380.
11. Mishell D.R., Droegemueller W., Herbst A.L. Comprehensive gynecology 1997, Mosby, St. Louis. 3rd ed.
12. Flegal K.M., Carroll M.D., Ogden C.L., Curtin L.R. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010, 303:235-241.
13. American Cancer Society What are the risk factors for endometrial cancer development? 2012, (last accessed 19.02.12). http://www.cancer.org/Cancer/EndometrialCancer/DetailedGuide/endometrial-uterine-cancer-risk-factors.
14. Cook L.S., Weiss N.S., Doherty J.A., Chen C. Endometrial cancer. Cancer epidemiology and prevention 2006, Oxford University Press, New York. 3rd ed. D. Schottenfeld, J.F. Fraumeni (Eds.).
15. Chang S.C., Lacey J.V., Brinton L.A., Hartge P., Adams K., Mouw T., et al. Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study. Cancer Epidemiol Biomarkers Prev 2007, 16(4):723-730.
16. Kaaks R., Lukanova A., Kurzer M.S. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 2002, 11(12):1531-1543.
17. Reeves K.W., Carter G.C., Rodabough R.J., Lane D., McNeeley S.G., Stefanick M.L., et al. Obesity in relation to endometrial cancer risk and disease characteristics in the Women's Health Initiative. Gynecol Oncol 2011, 121(2):376-382.
18. Felix A.S., Linkov F., Maxwell G.L., Ragin C., Taioli E. Racial disparities in risk of second primary cancers in endometrial cancer patients: Analysis of SEER Data. Int J Gynecol Cancer 2011, 21(2):309-315.
19. Felix A.S., Weissfeld J.L., Stone R.A., Bowser R., Chivukula M., Edwards R.P., et al. Factors associated with Type I and Type II endometrial cancer. Cancer Causes Control 2010, 21(11):1851-1856.
20. Linkov F., Edwards R., Balk J., Yurkovetsky Z., Stadterman B., Lokshin A., et al. Endometrial hyperplasia, endometrial cancer and prevention: gaps in existing research of modifiable risk factors. Eur J Cancer 2008, 44(12):1632-1644.